Use of VESsel GENeration with Optical Coherence Tomography Angiography and Fluorescein Angiography for Detection and Quantification of Vascular Changes in Mild and Moderate Diabetic Retinopathy

Author:

DuPont Mariana12ORCID,Arthur Edmund3,Shihab Yazen4,Kenny Madelyn3,Ravichandran Swetha3ORCID,Parsons-Wingerter Patricia5,Vyas Ruchi6,Murray Matthew C.7,Predovic Marina7,Lim Shiyin7,Jacobs Nicole7,Ramesh Sneha7,Vu Amanda7,Sekaran Srinivaas7,Chalam Kakarla V.8,Moorthy Ramana S.9,Crosson Jason10,Mason John10,Grant Maria B.1

Affiliation:

1. Department of Ophthalmology and Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA

2. Department of Hematology-Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA

3. School of Optometry, University of Alabama at Birmingham, Birmingham, AL 35294, USA

4. Birmingham School of Medicine, University of Alabama, Birmingham, AL 35233, USA

5. National Aeronautics and Space Administration (NASA), Washington, DC 20546, USA

6. Mori Associates, Ames Research Center, National Aeronautics and Space Administration (NASA), Moffett Field, CA 94035, USA

7. Blue Marble Space Institute of Science, Ames Research Center, NASA, Moffett Field, CA 94035, USA

8. Department of Ophthalmology, Loma Linda University Health Care, Loma Linda, CA 92354, USA

9. Associated Vitreoretinal and Uveitis Consultants, Indianapolis, IN 46290, USA

10. Retina Consultants of Alabama Birmingham, Birmingham, AL 35233, USA

Abstract

(1) Background: Previously, VESsel GENeration (VESGEN) software was used to map and quantify vascular changes observed on fluorescein angiography (FA) in subjects (n = 15 eyes) with retinal pathology ranging from mild non-proliferative diabetic retinopathy (NPDR) to proliferative diabetic retinopathy (PDR). In the current study, we used VESGEN for the assessment of individuals with early-stage NPDR imaged by FA (Cohort 1) and by optical coherence tomography angiography (OCTA; Cohort 2). (2) Methods: Cohort 1 included type 2 diabetics (T2D), represented 21 eyes (ranging from no DR to moderate DR), and also included nondiabetic controls (NDC; n = 15 eyes). Cohort 2 consisted of 23 eyes from T2D subjects (including no DR subjects and moderate DR subjects) and NDC (n = 18 eyes). (3) Results: In the FA-VESGEN study, total tortuosity (Tv) of microvessels (G ≥ 6) increased in T2D with mild DR compared to the controls. In contrast, the VESGEN analysis of OCTA images showed that vessel length (characterized as density) was lower in T2D subjects before the diagnosis of DR and following the diagnosis of DR when compared to the controls. Additionally, T2D showed a significant decrease in vessel area (density). (4) Conclusions: FA elucidated the vessel morphology of small-generation microvessels to a greater degree than OCTA; however, OCTA identified changes in vessel density better than FA. VESGEN analysis can be used with both standard FA and OCTA to facilitate our understanding of early events in DR, including before the clinical diagnosis of DR.

Funder

National Eye Institute

UAB ICAR Pilot Grant

Publisher

MDPI AG

Reference27 articles.

1. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy;Lin;J. Diabetes Investig.,2021

2. Shukla, U.V., and Tripathy, K. (2024). Diabetic Retinopathy. StatPearls, StatPearls Publishing.

3. Modi, P., and Arsiwalla, T. (2024). Hypertensive Retinopathy. StatPearls, StatPearls Publishing.

4. Clinical predictors of diabetic retinopathy progression: A systematic review;Ghamdi;Curr. Diabetes Rev.,2020

5. Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study;Grunwald;Arch. Ophthalmol.,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3